BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27603749)

  • 1. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
    Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
    Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.
    Poynter JN; Richardson M; Blair CK; Roesler MA; Hirsch BA; Nguyen P; Cioc A; Warlick E; Cerhan JR; Ross JA
    Cancer Epidemiol; 2016 Feb; 40():134-40. PubMed ID: 26720913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis.
    Schnatter AR; Glass DC; Tang G; Irons RD; Rushton L
    J Natl Cancer Inst; 2012 Nov; 104(22):1724-37. PubMed ID: 23111193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.
    Kristinsson SY; Björkholm M; Hultcrantz M; Derolf ÅR; Landgren O; Goldin LR
    J Clin Oncol; 2011 Jul; 29(21):2897-903. PubMed ID: 21690473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
    Björkholm M; Derolf AR; Hultcrantz M; Kristinsson SY; Ekstrand C; Goldin LR; Andreasson B; Birgegård G; Linder O; Malm C; Markevärn B; Nilsson L; Samuelsson J; Granath F; Landgren O
    J Clin Oncol; 2011 Jun; 29(17):2410-5. PubMed ID: 21537037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
    Rollison DE; Shain KH; Lee JH; Hampras SS; Fulp W; Fisher K; Al Ali NH; Padron E; Lancet J; Xu Q; Olesnyckyj M; Kenvin L; Knight R; Dalton W; List A; Komrokji RS
    Cancer Med; 2016 Jul; 5(7):1694-701. PubMed ID: 27098006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
    Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
    Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study.
    Ciccone G; Mirabelli D; Levis A; Gavarotti P; Rege-Cambrin G; Davico L; Vineis P
    Cancer Genet Cytogenet; 1993 Jul; 68(2):135-9. PubMed ID: 8353805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes.
    Goldin LR; Kristinsson SY; Liang XS; Derolf AR; Landgren O; Björkholm M
    J Clin Oncol; 2012 Jan; 30(2):179-83. PubMed ID: 22162584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H; Malmgren J; De Roos AJ
    Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.
    Ertz-Archambault N; Kosiorek H; Taylor GE; Kelemen K; Dueck A; Castro J; Marino R; Gauthier S; Finn L; Sproat LZ; Palmer J; Mesa RA; Al-Kali A; Foran J; Tibes R
    JAMA Oncol; 2017 Jul; 3(7):936-943. PubMed ID: 28152123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
    Jonsdottir G; Björkholm M; Turesson I; Hultcrantz M; Diamond B; Porwit A; Landgren O; Kristinsson SY
    Eur J Haematol; 2021 Aug; 107(2):275-282. PubMed ID: 33966293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
    Khan N; Patel D; Trivedi C; Kavani H; Pernes T; Medvedeva E; Lewis J; Xie D; Yang YX
    Am J Gastroenterol; 2021 Apr; 116(4):741-747. PubMed ID: 33982944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-acquired infections and their association with myeloid malignancies.
    Titmarsh GJ; McMullin MF; McShane CM; Clarke M; Engels EA; Anderson LA
    Cancer Epidemiol; 2014 Feb; 38(1):56-61. PubMed ID: 24275260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
    Freedman RA; Seisler DK; Foster JC; Sloan JA; Lafky JM; Kimmick GG; Hurria A; Cohen HJ; Winer EP; Hudis CA; Partridge AH; Carey LA; Jatoi A; Klepin HD; Citron M; Berry DA; Shulman LN; Buzdar AU; Suman VJ; Muss HB
    Breast Cancer Res Treat; 2017 Jan; 161(2):363-373. PubMed ID: 27866278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzene Exposure Response and Risk of Myeloid Neoplasms in Chinese Workers: A Multicenter Case-Cohort Study.
    Linet MS; Gilbert ES; Vermeulen R; Dores GM; Yin SN; Portengen L; Hayes RB; Ji BT; Lan Q; Li GL; Rothman N;
    J Natl Cancer Inst; 2019 May; 111(5):465-474. PubMed ID: 30520970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
    Kaplan HG; Malmgren JA; Atwood MK
    BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.
    Kaplan HG; Malmgren JA; Li CI; Calip GS
    Breast Cancer Res Treat; 2013 Dec; 142(3):629-36. PubMed ID: 24265034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan.
    Ugai T; Matsuo K; Sawada N; Iwasaki M; Yamaji T; Shimazu T; Goto A; Inoue M; Kanda Y; Tsugane S;
    Int J Cancer; 2018 Mar; 142(6):1130-1138. PubMed ID: 29076523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.